natgillin/translations-raw huggingface dataset:
Redness inside the ear
crvenilo u uhu kvržica u dojci
redness inside the ear* breast mass*
crvenilo unutrašnjosti uha* kvržica u dojci
redness of skin
crvenilo kože
Redness of the eye, small particles or spots in your vision (floaters), eye pain,
crvenilo oka, male čestice ili mrlje u vidnom polju (plutajuće čestice), bol u oku,
Redness of the skin
crvenilo kože
redness of the skin (erythema)
crvenilo kože (eritem)
redness of the skin (erythema) ,
(crvenilo kože (eritem),
redness of the skin (erythema), excessive sweating (hyperhidrosis), loss of sensation or numbness of the face, night sweats
crvenilo kože (eritem), prekomjerno znojenje (hiperhidroza), gubitak osjetljivosti ili utrnulost lica, noćna znojenja
redness of the skin (flushing);
crvenilo kože (crvenilo uz osjećaj vrućine);
Redness of the skin in the area around the catheter
Crvenilo kože u području oko katetera
Redness of your skin.
crvenilo kože
redness on and around the penis
crvenilo na i oko penisa
Redness or induration >2cm in diameter was reported in 22.6 % and 13.9 % of children respectively.
Crvenilo promjera ≥2 cm je zabilježeno u 22,6%, a otvrdnuće promjera ≥2 cm u 13,9% djece.
Redness or pain at the injection site
crvenilo ili bol na mjestu primjene injekcije
redness or rash at the site of patch application
crvenilo ili osip na mjestu primjene flastera
redness or swelling around a wound
crvenilo ili oteklina oko rane
redness or swelling at the injection site
crvenilo ili oticanje na mjestu injiciranja
Redness or swelling at the site where the needle entered the body
crvenilo ili otečenost na mjestu uboda iglom
redness or swelling where the injection was given
crvenilo ili oticanje na mjestu davanja injekcije
redness*,
crvenilo*,
redness, bumps or swelling of the tongue;
crvenilo, kvržice ili oticanje jezika;
Redness, burning and pain at the site of injection.
Crvenilo, pečenje i bol na mjestu injekcije
Redness, chapping or cracking of the skin
crvena, isušena ili ispucala koža
redness, heat, unusual swelling of skin or joint abdominal pain/tenderness and/or change in bowel function
crvenila, osjećaja vrućine, neuobičajenog oticanja kože ili zglobova bolova u trbuhu/osjetljivosti trbuha na dodir i/ili promjena u radu crijeva
redness, increased sweating
crvenilo, pojačano znojenje
redness, increased sweating, itching
crvenilo, pojačano znojenje, svrbež
redness, itching of the eye, eye infections, watery eyes
crvenilo, svrbež oka, infekcije oka, suzne oči
redness, itching, swelling, pain/tenderness where the medicine was injected (local injection site reactions)
crvenilo, svrbež, oticanje, bol/osjetljivost na mjestu injiciranja lijeka (lokalne reakcije na mjestu injiciranja)
Redness, often associated with blisters, may appear on the skin or on mucous membranes, such as inside the mouth, the genital areas or the eyelids, and fever may be present.
Na koži ili sluznicama, primjerice u ustima, na genitalijama ili kapcima, može se pojaviti crvenilo, često praćeno mjehurićima, a moguća je i vrućica.
Redness, often associated with blisters, may appear on the skin or on mucous membranes, such as inside the mouth, the genital areas or the eyelids, and fever may be present. recurrence of a previous Hepatitis B infection
Na koži ili sluznicama, primjerice u ustima, na genitalijama ili kapcima može se pojaviti crvenilo, često praćeno mjehurićima, a moguća je i vrućica. povratak ranije hepatitis B infekcije
redness, pain, blisters and swelling of the palms of the hands or soles of the feet (hand-foot skin reaction)
crvenilo, bol, mjehuri i oticanje dlanova i tabana (kožna reakcija na šakama i stopalima)
redness, peeling, tenderness, pain, or blistering on the fingers or feet,
crvenilo, ljuštenje, osjetljivost, bol ili plikovi na prstima ili stopalima,
redness, soreness and swelling of the skin on the hands and feet (hand-foot syndrome)
crvenilo, bolno na dodir i oticanje kože na šakama i stopalima (sindrom šaka-stopalo)
redness, soreness and swelling of the skin on the hands and feet (hand-foot syndrome)
crvenilo, bolnost na dodir i oticanje kože na šakama i stopalima (sindrom šaka-stopalo)
Redness, swelling or pain in the mouth or throat, difficulty in speaking, hoarseness
Crvenilo, oticanje ili bol u ustima ili grlu, otežan govor, promuklost
Redness, swelling or pain in the mouth or throat, difficulty in speaking, hoarseness, cough
Crvenilo, oticanje ili bol u ustima ili grlu, otežan govor, promuklost, kašalj
redness, swelling or sores in your mouth and/or throat
crvenilo, oticanje ili ranice u ustima i/ili grlu
Redness, swelling, and itching can occur at the site of insulin injection.
Na mjestu injekcije inzulina mogu se javiti crvenilo, oteklina i svrbež.
Redness, swelling, bruising or itching at the injection site.
Crvenilo, oticanje, modrice ili svrbež na mjestu primjene.
Redness, swelling, discolouration, inflammation, pain, hypersensitivity, necrosis and non-specific reactions were significantly associated with 250 microgram (8.0 million IU) Betaferon treatment.
Crvenilo, oticanje, promjena boje, upala, bol, preosjetljivost, nekroza i nespecifične reakcije značajno su povezane s liječenjem lijekom Betaferon 250 mikrograma (8,0 milijuna IU).
redness, swelling, numbness/tingling, or pain and/or skin peeling in hands and/or feet (called hand-foot syndrome) low blood levels of a protein called albumin
crvenilo, oticanje, utrnulost/trnci ili bol i/ili ljuštenje kože na šakama i/ili stopalima (što se naziva sindromom šaka-stopalo) niske razine albumina (jedne vrste proteina) u krvi
redness, swelling, pain on the palms of your hands and soles of your feet (hand-foot syndrome)
crvenilo, oteklina, bol u dlanovima šaka i tabanima stopala (sindrom šaka-stopalo)
Redraw the needle a little bit back within the vial so that the needle tip rests at the lowest point of the vial.
Povucite iglu malo prema nazad unutar bočice tako da se vrh igle nalazi na najnižoj točki bočice.
Reduce 1 dose level and follow with WBC Growth Factors
Smanjenje doza za 1 razinu i zatim primjena čimbenika rasta bijelih krvnih stanica
Reduce 5-FU dose by an additional 25% (1350 mg/m2)
za dodatnih 25% (1350 mg/m2)
Reduce alcohol and caffeine consumption
manjite konzumaciju alkohola i kofeina
Reduce Bortezomib Accord to 1.0 mg/m2 or
Smanjiti dozu Bortezomib Accorda na 1,0 mg/m2 ili
Reduce Bortezomib Hospira to 0.7 mg/m2 in the first treatment cycle.
U prvom ciklusu liječenja smanjiti dozu lijeka Bortezomib Hospira na 0,7 mg/m2.
Reduce Bortezomib Hospira to 1.0 mg/m2 or
Smanjiti dozu lijeka Bortezomib Hospira na 1,0 mg/m
Reduce Bortezomib SUN to 1.0 mg/m2 or
Smanjiti dozu Bortezomib SUN-a na 1,0 mg/m2 ili
Reduce by 1 dose level for 5-FU and irinotecan.
Smanjiti dozu 5-FU i irinotekana za 1 razinu.
Reduce by 1 dose level from previous level
Smanjiti za 1 razinu doze od prethodne razine
reduce discomfort.
smanjenje nelagode.
Reduce doses 1 dose level from Day 8 doses
manjenje razine doza 8. dana za 1 razinu
Reduce doses 2 dose levels from Day 1 doses
manjenje razine doza 1. dana za 2 razine
Reduce intake of food that can cause heartburn.
smanjite unos hrane koja može uzrokovati žgaravicu.
reduce milk leakage at drying off (the point at which the cow is no longer milked),
manjenje curenja mlijeka tijekom zasušivanja (točka u kojoj se krave više ne muzu),
reduce milk leakage at drying off,
manjilo curenje mlijeka tijekom isušivanja,
Reduce ONIVYDE dose to 50 mg/m2
Smanjiti dozu lijeka ONIVYDE na 50 mg/m2 Smanjiti dozu 5-FU
Reduce ONIVYDE dose to 60 mg/m2 Reduce 5-FU dose by 25% (1800 mg/m2)
Smanjiti dozu lijeka ONIVYDE na 60 mg/m2 Smanjiti dozu 5-FU za 25% (1800 mg/m2)
Reduce ONIVYDE dose to 60 mg/m2 Reduce 5-FU dose by 25% (1800 mg/m2).
Smanjiti dozu lijeka ONIVYDE na 60 mg/m2 Smanjiti dozu 5-FU za 25% (1800 mg/m2).
Reduce only interferon alfa2b dose (see note 2) if:
Smanjiti samo dozu interferona alfa-2b (vidjeti napomenu 2), ako:
Reduce only ribavirin daily dose (see note 1) if:
Smanjiti samo dnevnu dozu ribavirina (vidjeti napomenu 1) ako:
Reduce only ribavirin daily dose (see note 1), if:
Smanjiti samo dnevnu dozu ribavirina (vidjeti napomenu 1) ako:
Reduce or withhold dose of cinacalcet.
Smanjite ili privremeno obustavite dozu sinakalceta.
Reduce or withhold dose of Mimpara.
Smanjite ili privremeno obustavite dozu Mimpare.
Reduce pravastatin dose by
Dozu pravastatina treba
Reduce rate of infusion to 0.875 mg/m2/h.
Smanjiti brzinu infuzije na 0,875 mg/m2/sat.
Reduce Ribavirin Mylan dose* if:
Smanjiti dozu lijeka Ribavirin Mylan* ako je:
Reduce ribavirin to 600 mg
manjiti ribavirin na 600 mg
Reduce subsequent dose only if criteria in Table 4 are met.
Sljedeću dozu smanjite samo ako nisu ispunjeni kriteriji iz tablice 4.
Reduce the dose by 20%.
Smanjiti dozu za 20%.
Reduce the risk of kidney stones by drinking sufficient water. live in a place or are on holiday in a place where the weather is warm.
Smanjite rizik od nastanka bubrežnih kamenaca tako da pijete dovoljno vode.
reduce the risk of new infections of the udder during the dry period,
manjenje rizika od novih infekcija vimena tijekom suhostaja,
reduce the risk of new intramammary infections during the dry period, reduce discomfort.
manjio rizik novih intramamarnih infekcija tijekom suhostaja, smanjila nelagoda.
Reduce the risk of overheating by drinking sufficient water and keeping cool are underweight, or have lost a lot of weight as Zonisamide Mylan can cause you to lose more weight.
Opasnost od pregrijavanja smanjite tako da pijete dovoljno vode i budete rashlađeni. ako je Vaša tjelesna težina manja od prosječne ili ako ste mnogo izgubili na težini, jer Zonisamid Mylan može izazvati daljnji gubitak težine.
Reduce the signs and symptoms of your disease
umanjili znakovi i simptomi bolesti
Reduce the signs and symptoms of your disease
umanjili znakovi i simptomi bolesti poboljšala Vaša fizička funkcionalnost.
reduce the signs and symptoms of your disease,
ublažili znakovi i simptomi Vaše bolesti,
Reduce the signs and symptoms of your disease,
umanjili znakovi i simptomi bolesti
Reduce the signs and symptoms of your disease,
umanjili znakovi i simptomi bolesti poboljšala Vaša fizička funkcionalnost.
reduce the signs and symptoms of your disease, improve your physical function.
umanjili znakovi i simptomi bolesti poboljšala Vaša fizička funkcionalnost.
Reduce the signs and symptoms of your disease.
manjenja znakova i simptoma vaše bolesti.
Reduce the signs and symptoms of your disease.
Umanjili znakovi i simptomi bolesti.
Reduce to 0.5 MU (5 micrograms)/kg/day
Smanjiti na 0,5 MU (5 mikrograma)/kg/dan
Reduce to 0.5 MU/kg/day (5 μg/kg/day)
Smanjiti na 0,5 MU/kg na dan (5 μg/kg na dan)
Reduce VELCADE to 0.7 mg/m2 in the first treatment cycle.
U prvom ciklusu liječenja smanjiti dozu VELCADEa na 0,7 mg/m2.
Reduce VELCADE to 1.0 mg/m2 or
Smanjiti dozu VELCADEa na 1,0 mg/m2 ili
Reduce weight (if overweight)
manjite tjelesnu težinu (ako je prekomjerna)
reduced ability to sweat, which can cause fever and heatstroke. urgent need to urinate;
manjena mogućnost znojenja, što može uzrokovati vrućicu i toplinski udar. hitna potreba za mokrenjem;
Reduced acoustic startle response was observed in juvenile rats 1 – 2 weeks after exposure at > 2 times the human therapeutic exposure.
U mladih je štakora nakon 1-2 tjedna izloženosti > 2 puta većoj od terapijske izloženosti u ljudi opažena umanjena reakcija straha na akustične podražaje.
Reduced activity and lack of appetite on the day of vaccination very commonly occurs and/or a transient swelling (max diameter: 10 cm) for up to two weeks may arise at the site of injection.
Vrlo često se javlja smanjena aktivnost i gubitak apetita poslije cijepljenja i/ili prolazna otečenost (max. promjera 10cm.) na mjestu uboda koja traje i do dva tjedna.
Reduced alertness
manjena budnost
reduced appetite
manjen apetit
Reduced appetite
manjen tek
reduced appetite
manjeni apetit
reduced appetite
manjenje teka
reduced appetite weakness
manjeni apetit slabost
reduced blood cells called „platelets‟ - can increase your risk for bleeding or bruising,
manjenje broja krvnih stanica koje se nazivaju “trombociti” - moţe se povećati rizik od krvarenja i nastanka modrica,
Reduced blood flow in the heart vessels, faster heartbeat
manjen protok krvi kroz krvne žile srca, ubrzani otkucaji srca
reduced blood flow in the heart vessels, faster heartbeat
manjen protok krvi kroz krvne žile srca, ubrzani rad srca
Reduced blood flow in the heart vessels, faster heartbeat
manjen protok krvi kroz krvne žile, ubrzan rad srca
Reduced blood flow to the heart
Smanjen dotok krvi u srce
Reduced blood platelet count below the normal lower limit (known as thrombocytopenia).
Smanjen broj krvnih pločica ispod donje granice normalnih vrijednosti (poznato pod nazivom trombocitopenija).
Reduced blood platelets, which increases risk of bleeding or bruising psoriasis
manjenje broja trombocita koje povećava rizik od krvarenja ili modrica psorijaza
reduced blood pressure,
niženi krvni tlak,
reduced blood pressure, feeling faint (syncope)
manjen krvni tlak, gubitak svijesti (sinkopa)
reduced blood pressure, feeling faint (syncope)
nižen krvni tlak, gubitak svijesti (sinkopa)
reduced blood proteins
niženi proteini u krvi
reduced blood supply to the brain or stroke,
manjen dotok krvi u mozak ili moždani udar,
Reduced clearance of ceftazidime was observed in elderly patients, which was primarily due to age- related decrease in renal clearance of ceftazidime.
Smanjen klirens ceftazidima primijećen je kod starijih bolesnika, što je prvenstveno bila posljedica dobno uvjetovanog smanjenja bubrežnog klirensa ceftazidima.
Reduced dose (50%)
Smanjena doza (50%)
Reduced dose (75%)
Smanjena doza (75%)
Reduced dose (once daily)
Smanjena doza (jednom dnevno)
Reduced doses may be achieved by transfer of an appropriate volume of the resultant solution to an infusion bag, based upon ceftazidime and avibactam content of 167.3 mg/mL and
Manje doze mogu se postići prijenosom odgovarajućeg volumena dobivene otopine u infuzijsku vrećicu, izračunatog na temelju sadržaja ceftazidima od 167,3 mg/ml i avibaktama od 41,8 mg/ml.
Reduced exposure may also occur with other inducers e.g. phenytoin, carbamazepine, barbiturates or St. John’s Wort (hypericum perforatum).
Smanjena raspoloživost može se pojaviti kod primjene erlotiniba s ostalim induktorima, npr. fenitoinom, karbamazepinom, barbituratima ili gospinom travom (hypericum perforatum).
Reduced F1 body weight reversed post-weaning with the exception of F1 females from dams treated perinatally (end of gestation to 10 days postpartum) at 5 mg/kg/day with no other effects on development.
Smanjena tjelesna težina mladunčadi F1 generacije vratila se u normalu nakon sisanja, osim kod ženske mladunčadi F1 generacije u okotu ženki koje su perinatalno (od kraja gestacije do 10 dana nakon poroda) primale doze od 5 mg/kg na dan, ali nisu primijećeni nikakvi drugi učinci na razvoj.
reduced feeling of sensitivity especially on the skin
manjen osjećaj osjetljivosti, osobito kože
reduced feeling of sensitivity especially on the skin
manjen osjećaj osjetljivosti, osobito kože,
Reduced flow of bile from the gallbladder and/or inflammation of the gallbladder.
Smanjeni dotok žuči iz žučnog mjehura i/ili upala žučnog mjehura.
reduced function of the adrenal gland (which could show as tiredness)
manjena funkcija nadbubrežne žlijezde (koja se može očitovati kao umor)
reduced function of the adrenal gland (which may show as tiredness)
manjena funkcija nadbubrežne žlijezde (što se može očitovati kao umor)
reduced function of the thyroid gland
manjena funkcija štitne žlijezde
Reduced function of your body’s immune system.
manjena funkcija imunološkog sustava
Reduced functioning of your kidneys
manjena funkcija bubrega
reduced heart function
manjena srčana funkcija
reduced heart rate
usporeni puls
Reduced heart rate and temporary AV-block can be seen after administration of dexmedetomidine.
Nakon primjene deksmedetomidina može doći do smanjenja srčane frekvencije i prolaznog AV bloka.
Reduced hepatic function is a risk factor for bleeding and should be considered before initiating Zontivity.
Smanjena funkcija jetre faktor je rizika za krvarenje te se mora uzeti u obzir prije početka liječenja lijekom Zontivity.
reduced kidney function
manjena bubrežna funkcija
Reduced kidney function.
manjena funkcija bubrega
Reduced levels of calcium in the blood (hypocalcaemia), sometimes leading to muscle cramps, dry skin, burning sensation, have been reported in patients treated with Zoledronic acid Teva.
Smanjena razina kalcija u krvi (hipokalcemija), koja ponekad dovodi do mišićnih grčeva, suhe kože, osjećaja pečenja, zabilježena je u bolesnika liječenih Zoledronatnom kiselinom Teva.
Reduced levels of ciclosporin, mycophenolate mofetil and tacrolimus have been reported in transplant patients when co-administered with sevelamer hydrochloride without any clinical consequences (e.g., graft rejection).
Zabilježene su snižene vrijednosti ciklosporina, mikofenolat mofetila i takrolimusa u transplantiranih bolesnika kod istodobne primjene sevelamerklorida, bez kliničkih posljedica (npr. odbacivanja presatka).
Reduced levels of ciclosporin, mycophenolate mofetil and tacrolimus have been reported in transplant patients when coadministered with sevelamer hydrochloride without any clinical consequences (i.e graft rejection).
Zabilježene su snižene vrijednosti ciklosporina, mikofenolat mofetila i takrolimusa u transplantiranih bolesnika kod istodobne primjene sevelamerklorida, bez kliničkih posljedica (npr. odbacivanja presatka).
reduced levels of white blood cells (which fight infection) and red blood cells (which carry oxygen around the body)
nižena razina bijelih krvnih stanica (koje suzbijaju infekciju) i crvenih krvnih stanica (koje nose kisik po organizmu)
Reduced liver function.
manjena funkcija jetre
Reduced magnesium, phosphate, potassium, calcium or sodium in the blood, fluid overload, increased uric acid or lipids in the blood, decreased appetite, increased acidity of the blood, other changes in the blood salts (seen in blood tests)
nižen magnezij, fosfati, kalij, kalcij ili natrij u krvi, opterećenje tekućinom, povišena mokraćna kiselina ili lipidi u krvi, smanjen apetit, povišena kiselost krvi, druge promjene u elektrolitima krvi (viđene na krvnim pretragama)
reduced magnesium, phosphate, potassium, calcium or sodium in the blood, fluid overload, increased uric acid or lipids in the blood, decreased appetite, increased acidity of the blood, other changes in the blood salts (seen in blood tests)
nižena razina magnezija, fosfata, kalija, kalcija ili natrija u krvi, opterećenje tekućinom, povišena razina mokraćne kiseline ili lipida u krvi, smanjen tek, povišena kiselost krvi, druge promjene u elektrolitima u krvi (vidljivo u nalazu pretraga krvi )
Reduced magnesium, phosphate, potassium, calcium or sodium in the blood, fluid overload, increased uric acid or lipids in the blood, decreased appetite, increased acidity of the blood, other changes in the blood salts (seen in blood tests)
niženi magnezij, fosfat, kalij, kalcij ili natrij u krvi, preopterećenje tekućinom, povišena mokraćna kiselina ili lipidi u krvi, smanjen apetit, povećana kiselost krvi, druge promjene elektrolita u krvi (vide se na krvnim pretragama)
reduced number of blood cells (neutropenia or lymphopenia, thrombocytopenia)
manjen broj krvnih stanica (neutropenija ili limfopenija, trombocitopenija)
reduced number of blood cells (neutropenia, thrombocytopenia, lymphopenia, leukopenia)
manjen broj krvnih stanica (neutropenija, trombocitopenija, limfopenija, leukopenija)
Reduced number of platelets (thrombocytopenia) and white blood cells (leukopenia), shortage of certain white blood cells (granulocytopenia).
manjeni broj krvnih pločica (trombocitopenija) i bijelih krvnih stanica (leukopenija), manjak određenih vrsta bijelih krvnih stanica (granulocitopenija).
Reduced number of platelets in your blood (which can affect clotting)
Smanjen broj trombocita u krvi (može utjecati na zgrušavanje)
reduced number of white blood cells
manjeni broj bijelih krvnih stanica
Reduced number of white blood cells (leucopenia), low platelet count (thrombocytopenia), allergic reaction (e.g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), excess sugar in blood , uncontrollable twitching or jerking movements, heart attack, irregular heart beat, inflammation of the blood vessels, inflamed pancreas, inflammation of the stomach lining (gastritis), inflammation of the liver, yellowing of the skin (jaundice), increased levels of hepatic enzymes with jaundice, rapid swelling of skin and mucosa (angioedema), severe skin reactions, hives (urticaria), severe allergic reactions with blistering eruptions of the skin and mucous membranes (exfoliative dermatitis, Stevens-Johnson-Syndrome), increased sensitivity of the skin to sun.
Smanjeni broj bijelih krvnih stanica (leukopenija), niski broj trombocita (tromobcitopenija), alergijska reakcija (npr. osip, svrbež, otežano disanje, piskanje pri disanju, otečenost lica ili niski krvni tlak), povećane vrijednosti šećera u krvi, nekontrolirani pokreti grčenja ili trzanja, srčani udar, nepravilno kucanje srca, upala krvnih žila, upala gušterače, upala želučane sluznice (gastritis), upala jetre, žutilo kože (žutica), povišene vrijednosti jetrenih enzima sa žuticom, brzo oticanje kože i sluznice (angioedem), teške reakcije kože, koprivnjača (urtikarija), teške alergijske reakcije s izbijanjem mjehurića po koži i membranama sluznice (eksfolijativni dermatitis, Stevens-Johnsonov sindrom), pojačana osjetljivost kože na sunce.
Reduced number of white blood cells in the blood
manjenje broja leukocita u krvi
reduced number of white blood cells, swollen lymph glands (lymphadenopathy)
niženi broj bijelih krvnih stanica, otečeni limfni čvorovi (limfadenopatija)
reduced numbers of blood cells (autoimmune haemolytic anaemia, autoimmune aplastic anaemia)
manjen broj krvnih stanica (autoimuna hemolitička anemija, autoimuna aplastična anemija)
Reduced offspring body weights were observed during the pre-weaning and post-weaning periods at 3 mg/kg/day.
Pri dozi od 3 mg/kg na dan opaženo je smanjenje tjelesne težine mladunčadi u razdoblju prije i nakon odbijanja od sisanja.
Reduced or absent - galactosidase activity results in the accumulation of GL-3 in the lysosomes of many cell types including the endothelial and parenchymal cells, ultimately leading to life-threatening clinical deteriorations as a result of renal, cardiac and cerebrovascular complications.
Smanjena aktivnost α-galaktozidaze ili njezin potpuni izostanak dovodi do kumulacije GL-3 u lizosomima mnogih vrsta stanica, uključujući stanice endotela i parenhimske stanice, što u konačnici dovodi do po život opasnih kliničkih pogoršanja kao posljedice bubrežnih, srčanih i cerebrovaskularnih komplikacija.
Reduced or absent -L-iduronidase activity results in the accumulation of the GAGs, dermatan sulfate and heparan sulfate in many cell types and tissues.
Smanjenje ili izostanak aktivnosti α-L-iduronidaze uzrokuje nakupljanje glikozaminoglikana, dermatan sulfata i heparan sulfata u različitim vrstama stanica i tkivima.
reduced plasma
koncentracije dolutegravira u
reduced platelets number just after the infusion – this can be reversed, but can be fatal in rare cases hearing loss, loss of other senses
manjenje broja krvnih pločica neposredno nakon infuzije – može se povući, ali u rijetkim slučajevima može imati i smrtni ishod gubitak sluha, gubitak drugih osjeta
reduced platelets number just after the infusion – this can be reversed, but can be fatal in rare cases hearing loss, loss of other senses.
manjenje broja krvnih pločica neposredno nakon infuzije – može se povući, ali u rijetkim slučajevima može imati i smrtni ishod gubitak sluha, gubitak drugih osjeta.
reduced red blood cells - can make you feel weak or short of breath or make your skin pale,
manjenje broja crvenih krvnih stanica - moţe izazvati osjećaj slabosti ili nedostatak zraka te bljedoću,
reduced resistance to infection or fever feeling tired or dizzy, having a lack of energy.
manjena otpornost na infekciju ili vrućicu osjećaj umora ili vrtoglavice, manjak energije.